about
Identification of patient subgroups and risk factors for persistent arm/shoulder pain following breast cancer surgery.Variations in potassium channel genes are associated with breast pain in women prior to breast cancer surgery.Trajectories of fear of recurrence in women with breast cancer.Gender Differences in Predictors of Quality of Life at the Initiation of Radiation Therapy.Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers.Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgeryCytokine gene associations with self-report ratings of morning and evening fatigue in oncology patients and their family caregivers.Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study.Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery.Differences in self-reported attentional fatigue between patients with breast and prostate cancer at the initiation of radiation therapyAssociations between catecholaminergic, GABAergic, and serotonergic genes and self-reported attentional function in oncology patients and their family caregivers.Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy.Patterns of change in cognitive function with anastrozole therapy.Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery.Differences in the symptom experience of older oncology outpatientsDifferences in morning and evening fatigue in oncology patients and their family caregivers.Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer.Associations between cytokine gene variations and self-reported sleep disturbance in women following breast cancer surgery.Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery.The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy.Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer.Exploratory Study of Associations Between DNA Repair and Oxidative Stress Gene Polymorphisms and Cognitive Problems Reported by Postmenopausal Women With and Without Breast CancerSymptom Science: Advocating for Inclusion of Functional Genetic Polymorphisms
P50
Q33578838-21C90D0F-34DA-48BF-81A8-D875432ACC5AQ33670792-64226340-EF94-454F-BD22-23CCA4C58325Q33792413-C65D3911-FC29-4395-8252-E76B00971443Q33800553-28D9245F-20EA-41DD-9639-92B30AFE5D09Q33809141-33ECAB78-7C1F-4CE7-9637-677A9577D5DEQ33839314-EC699EE9-8A93-4902-8E8A-839DF7D6EB8CQ33839327-0542B584-304D-4185-8EC4-AF26709F539DQ34529527-C9BECD45-E235-4F78-ADD9-DB881DB0CA20Q35091181-FB9E52A4-66EC-4484-9EDA-7321FB49C117Q35116057-647340B2-A373-4340-877B-243C24E1EACAQ35744329-3E40F9E1-706E-4572-B9B1-FBB91FB7CE91Q35851810-DD8D6288-3FBD-4A81-A4FD-B56D0E09CD33Q35883135-BC21A30B-B158-4481-922F-06B37A00BAF6Q36438840-70EAC5AE-CCE9-4BAF-A9E6-9415D91E6FD4Q37325103-48EFCDF2-6628-4535-A639-203C6A640811Q37402760-1E796781-73CD-475C-B777-3939B6D9FEBDQ37590124-85B1AF53-CC37-4F80-A509-88D7BBCD8783Q37624747-00F81A62-88B9-4567-BE25-85A6BBF795BFQ37653735-BAAD5E95-C29B-4B55-9B68-866100EA9D02Q41983968-43A11592-8E32-4514-98B5-E45FE2C2CAEAQ50554157-9FAFF2AC-08C3-4F56-97E0-42432156B7F8Q64939323-17A766AE-0FDA-4892-A53D-D3E8ED7F86B6Q91431817-ADF15419-AAB3-44DF-81D2-1B543D899EFEQ91516622-B4C44D04-DC58-478B-87B1-17DBE495A923
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
John D Merriman
@ast
John D Merriman
@en
John D Merriman
@es
John D Merriman
@nl
type
label
John D Merriman
@ast
John D Merriman
@en
John D Merriman
@es
John D Merriman
@nl
prefLabel
John D Merriman
@ast
John D Merriman
@en
John D Merriman
@es
John D Merriman
@nl
P108
P106
P31
P496
0000-0002-7113-5389